AVAH vs. EHAB, VMD, PNTG, HLTH, AHCO, ADUS, TVTX, ZIMV, LFMD, and TRDA
Should you be buying Aveanna Healthcare stock or one of its competitors? The main competitors of Aveanna Healthcare include Enhabit (EHAB), Viemed Healthcare (VMD), The Pennant Group (PNTG), Cue Health (HLTH), AdaptHealth (AHCO), Addus HomeCare (ADUS), Travere Therapeutics (TVTX), ZimVie (ZIMV), LifeMD (LFMD), and Entrada Therapeutics (TRDA). These companies are all part of the "medical" sector.
Aveanna Healthcare (NASDAQ:AVAH) and Enhabit (NYSE:EHAB) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, media sentiment, community ranking, institutional ownership, dividends, profitability and earnings.
Aveanna Healthcare has a beta of 2.03, suggesting that its stock price is 103% more volatile than the S&P 500. Comparatively, Enhabit has a beta of 1.96, suggesting that its stock price is 96% more volatile than the S&P 500.
88.0% of Aveanna Healthcare shares are held by institutional investors. 7.8% of Aveanna Healthcare shares are held by company insiders. Comparatively, 1.9% of Enhabit shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Aveanna Healthcare has a net margin of -7.10% compared to Enhabit's net margin of -7.69%. Enhabit's return on equity of 1.55% beat Aveanna Healthcare's return on equity.
Aveanna Healthcare currently has a consensus target price of $1.80, suggesting a potential downside of 20.00%. Enhabit has a consensus target price of $12.08, suggesting a potential upside of 21.08%. Given Enhabit's stronger consensus rating and higher possible upside, analysts clearly believe Enhabit is more favorable than Aveanna Healthcare.
Enhabit has lower revenue, but higher earnings than Aveanna Healthcare. Enhabit is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.
Aveanna Healthcare received 21 more outperform votes than Enhabit when rated by MarketBeat users. Likewise, 38.71% of users gave Aveanna Healthcare an outperform vote while only 13.64% of users gave Enhabit an outperform vote.
In the previous week, Enhabit had 1 more articles in the media than Aveanna Healthcare. MarketBeat recorded 1 mentions for Enhabit and 0 mentions for Aveanna Healthcare. Enhabit's average media sentiment score of 1.34 beat Aveanna Healthcare's score of 0.00 indicating that Enhabit is being referred to more favorably in the news media.
Summary
Aveanna Healthcare beats Enhabit on 9 of the 17 factors compared between the two stocks.
Get Aveanna Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for AVAH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AVAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aveanna Healthcare Competitors List
Related Companies and Tools
